Menu

Imperial Innovations' portfolio of companies

Imperial Innovations has a portfolio made up of 98 companies (as at 31 January 2015) covering a range of sectors, but primarily in the areas of therapeutics, medtech, engineering and ICT. Innovations manages its portfolio of companies actively, taking a seat on the board of companies it invests in and providing guidance on management recruitment, intellectual property strategy and overall company development.

The top 20 companies in Imperial Innovations portfolio by value represent 92% of the total value of the portfolio. This top group of companies, in addition to newly founded and seed-funded companies and the remainder of our accelerated growth portfolio, is the primary focus of our active portfolio management.

Top 20 companies by value


Company

Net Investment Carrying Value* (£ '000)

% issued share capital held*

Circassia 67,297 14.0%
Nexeon 34,086 40.0%
Veryan Medical 20,893 48.2%
Cell Medica 19,147 27.0%
Abzena plc 17,548 23.6%
PsiOxus Therapeutics 11,471 29.4%
Plaxica 9,447 45.7%
Oxford Immunotec 8,067 4.6%
Econic Technologies 6,145 56.1%
Autifony 6,060 25.7%
MISSION Therapeutics 6,011 21.2%
TopiVert 5,955 33.1%
Cortexica 5,428 30.0%
Abingdon Health 4,279 35.5%
EVO Electric 3,786 34.1%
Cambridge Communication Systems 3,672 9.0%
Crescendo Biologics 3,250 17.4%
Stanmore Implants Worldwide 3,134 16.4%
Just Yoyo 2,857 36.2%
Nascient 2,750 78.8%

*All figures are correct as of January 31st 2015